… risk and progression to enable a vision of precision medicine. David is currently leveraging his expertise and … populations, speed-to-market and ongoing validation of clinical benefit are more important now than ever before. …
… one hand we have a number of physicians, people who are in clinical practice and face these issues all the time and … would cure them. So I got very interested in what do we in medicine call the disease? What do we call the treatment? … it made me realize the need to question what we do in medicine. Just because a company says, "Here's a great drug …
